Human Longevity, Inc. Announces 10 Year Deal with AstraZeneca to Sequence and Analyze Patient Samples from AstraZeneca Clinical Trials
(SAN DIEGO, CA)—April 21, 2016—Human Longevity, Inc. (HLI), the genomics-based, technology-driven company worki...
StartUp Health Launches ‘Longevity Moonshot’ and Invests in Human Longevity, Inc. to Change Face of Aging
New York, NY (PRWEB)April 13, 2016 — StartUp Health, a global organization leading the movement to transform heal...
Human Longevity, Inc. Wins 2016 Bio-IT World Best Practice Award for the HLI Knowledgebase
Judges Honor Comprehensive Genome and Phenotype Database Curated with Proprietary Computational Tools by the Leadin...
Human Longevity, Inc. Announces Promotions and Additions to Leadership Team
Kenneth Bloom, M.D. is President and Ashley Van Zeeland, Ph.D. is Chief Technology Officer, Insurance Industry Lead...
- RT @BIOCOMCA: Our San Diego region takes #genomics to a whole new level w/ @AstraZenecaUS & @humanlongevity‘s giant genome pact: https://t.…
[1 day ago]
- RT @sandiegoscience: AstraZeneca, Venter’s Human Longevity ink huge genome sequencing pact: https://t.co/7sV7QQ3PSP @humanlongevity
[5 days ago]
- HLI Announces 10 Year Deal with @AstraZeneca to Sequence & Analyze Patient Samples from AstraZeneca Clinical Trials https://t.co/YSe7PoTzMZ
[7 days ago]
Using the combined power of our core areas of expertise—genomics, informatics, and stem cell therapies, we are tackling one of the greatest medical/scientific and societal challenges—aging and aging related diseases. –Dr. J. Craig Venter
The global market for healthy human longevity is enormous with total healthcare expenditures in those 65 and older running well over $7 trillion. We believe that HLI’s unique science and technology, along with our business leadership, will positively impact the healthcare market with novel diagnostics and therapeutics. –Dr. Robert Hariri
HLI is going to change the way medicine is practiced by helping to shift to a more preventive, genomic-based medicine model which we believe will lower healthcare costs. Our goal is not necessarily lengthening life, but extending a healthier, high performing, more productive life span. –Dr. J. Craig Venter
Between 1910 and 2010 improvements in medicine and sanitation increased the human lifespan by 50 percent from 50 to 75 years. Today with the emergence of exponential technologies such as those being pioneered and advanced by HLI we have the potential to meaningfully extend the lifespan even further. –Dr. Peter H. Diamandis